Back
Madrigal Pharmaceuticals 10K Form
Sell
43
MDGL
Madrigal Pharmaceuticals
Last Price:
215.99
Seasonality Move:
-4.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDGL News And Ratings
See the #1 stock for the next 7 days that we like better than MDGL
MDGL Financial Statistics
Sales & Book Value
| Annual Sales: | $150K |
|---|---|
| Cash Flow: | $-80.97M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $20.39 |
| Price / Book: | 10.31 |
Profitability
| EPS (TTM): | -19.98000 |
|---|---|
| Net Income (TTM): | $-373.63M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Madrigal Pharmaceuticals Earnings Forecast
Key Madrigal Pharmaceuticals Financial Ratios
- The Selling, General & Administrative Expenses for MDGL have been equal to 7,786.67% of Gross Profit Margin.
- The Interest Expense is -3.40% of Operating Income.
- Per Share Earnings over the last 23 years have been positive in 8 years.
Madrigal Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDGL |
| CUSIP: | 558868 |
| Website: | madrigalpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MDGL Technical Analysis vs Fundamental Analysis
Sell
43
Madrigal Pharmaceuticals (MDGL)
is a Sell
Is Madrigal Pharmaceuticals a Buy or a Sell?
-
Madrigal Pharmaceuticals stock is rated a Sell
The current Madrigal Pharmaceuticals [MDGL] share price is $210.08. The Score for MDGL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.